Kim DC - Search Results

1

Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models.

Kim W, Cho YA, Kim DC, Jo AR, Min KH, Lee KE. Kim W, et al. Among authors: kim dc. Cancers (Basel). 2021 Oct 30;13(21):5465. doi: 10.3390/cancers13215465. Cancers (Basel). 2021. PMID: 34771631 Free PMC article.

2

Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.

Jin H, Lee JS, Kim DC, Ko YS, Lee GW, Kim HJ. Jin H, et al. Among authors: kim dc, kim hj. Cancers (Basel). 2021 Apr 27;13(9):2105. doi: 10.3390/cancers13092105. Cancers (Basel). 2021. PMID: 33925516 Free PMC article.

3

Elevated Risk of Fluoropyrimidine-Associated Toxicity in European Patients with DPYD Genetic Polymorphism: A Systematic Review and Meta-Analysis.

Kim W, Cho YA, Kim DC, Lee KE. Kim W, et al. Among authors: kim dc. J Pers Med. 2022 Feb 6;12(2):225. doi: 10.3390/jpm12020225. J Pers Med. 2022. PMID: 35207713 Free PMC article.

4

Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.

Kim W, Cho YA, Kim DC, Lee KE. Kim W, et al. Among authors: kim dc. Pharmaceuticals (Basel). 2022 Apr 1;15(4):439. doi: 10.3390/ph15040439. Pharmaceuticals (Basel). 2022. PMID: 35455437 Free PMC article. Review.

5

Machine Learning Approaches for Assessing Risk Factors of Adrenal Insufficiency in Patients Undergoing Immune Checkpoint Inhibitor Therapy.

Kim W, Cho YA, Min KH, Kim DC, Lee KE. Kim W, et al. Among authors: kim dc. Pharmaceuticals (Basel). 2023 Aug 3;16(8):1097. doi: 10.3390/ph16081097. Pharmaceuticals (Basel). 2023. PMID: 37631013 Free PMC article.

6

Factors inducing cutaneous adverse reactions in cancer patients treated with PD-1 and PD-L1 inhibitors: a machine-learning algorithm approach.

Cho YA, Moon Y, Park W, Lee Y, Lee KE, Kim DC, Kim W. Cho YA, et al. Among authors: kim dc. Immunopharmacol Immunotoxicol. 2025 Feb;47(1):53-58. doi: 10.1080/08923973.2024.2430670. Epub 2024 Nov 22. Immunopharmacol Immunotoxicol. 2025. PMID: 39542723

7

Analysis of Risk Factors for Hepatotoxicity Induced by Immune Checkpoint Inhibitors.

Cho YA, Han JM, Kang SY, Kim DC, Youn YJ, Choi KH, Gwak HS. Cho YA, et al. Among authors: kim dc. J Immunother. 2021 Jan;44(1):16-21. doi: 10.1097/CJI.0000000000000347. J Immunother. 2021. PMID: 33290362

8

PD-1 Expression and its Correlation With Prognosis in Clear Cell Renal Cell Carcinoma.

Kim MH, Ko GH, Lee JH, Lee JS, Kim DC, Yang JW, An HJ, Na JM, Song DH. Kim MH, et al. Among authors: kim dc. In Vivo. 2021 May-Jun;35(3):1549-1553. doi: 10.21873/invivo.12409. In Vivo. 2021. PMID: 33910834 Free PMC article.

9

Programmed Death-Ligand 1 Expression and Its Correlation with Lymph Node Metastasis in Papillary Thyroid Carcinoma.

An HJ, Ko GH, Lee JH, Lee JS, Kim DC, Yang JW, Kim MH, Kim JP, Jung EJ, Song DH. An HJ, et al. Among authors: kim dc, kim jp, kim mh. J Pathol Transl Med. 2018 Jan;52(1):9-13. doi: 10.4132/jptm.2017.07.26. Epub 2017 Oct 3. J Pathol Transl Med. 2018. PMID: 28994272 Free PMC article.

10

Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis.

Koh HM, Kim DC. Koh HM, et al. Among authors: kim dc. Medicine (Baltimore). 2020 Aug 7;99(32):e21575. doi: 10.1097/MD.0000000000021575. Medicine (Baltimore). 2020. PMID: 32769903 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters